Stryker Starts 2023 with Strength Across Orthopedics

Stryker reported 1Q23 orthopedics sales of $2.5 billion, +12.1% compared to the first quarter of 2021.

The company faced a softer 1Q22 comparison because of the lingering omicron impact. While volumes have recovered since then, Stryker said that hospital staffing issues persist around the globe and supply chain “brush fires” occur with...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us